ANIK
ANIK
NASDAQ · Biotechnology

Anika Therapeutics Inc

$10.46
+0.16 (+1.55%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 25.13M 23.45M 26.68M
Net Income 5.79M 5.38M 7.18M
EPS
Profit Margin 23.0% 22.9% 26.9%
Rev Growth +24.1% -4.1% +21.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 37.86M 38.69M 41.86M
Total Equity 98.50M 99.18M 96.99M
D/E Ratio 0.38 0.39 0.43
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 9.68M 8.65M 11.22M
Free Cash Flow 5.88M 4.59M 6.09M